Durham, NC 的 食道腺癌 臨床試驗
10 項針對 食道腺癌 的研究正在 Durham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
招募中3 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
- University of North Carolina-Hillsborough Campus, Hillsborough · 距離 13 英里
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
招募中2/3 期
- University of North Carolina Medical Center, Chapel Hill · 距離 10 英里
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
招募中2 期
- Duke University Medical Center, Durham
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
招募中歡迎健康志工
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
招募中
- University of North Carolina School of Medicine, Chapel Hill · 距離 10 英里
Obeticholic Acid for Prevention in Barrett's Esophagus
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
招募中
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
招募中1 期
- Research Site, Durham
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
招募中2 期
- Durham VA Medical Center, Durham, NC, Durham
其他城市的 食道腺癌 試驗
- New York City, NY18 項研究
- Boston, MA13 項研究
- Houston, TX12 項研究
- Nashville, TN11 項研究
- Arlington, VA11 項研究
- Baldwin Park, CA9 項研究
- St. Louis, MO9 項研究
- Rochester, MN9 項研究
- Jacksonville, FL9 項研究
- Queens, NY9 項研究
- Los Angeles, CA9 項研究
- Dallas, TX8 項研究
Durham 的其他研究
- 乳癌64 項研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。